Drop the ingredient list of a thirteen-dollar moisturizer next to that of a prestige serum and you would normally expect the cheaper one to read thin. This one does the opposite, and the headline reason is ectoin at two percent, a concentration usually reserved for premium skincare priced three to five times higher, packed here into an ultra-lightweight microemulsion that costs about as much as a sandwich. The Ordinary built its reputation on stripping marketing markup out of clinically meaningful chemistry, and after years of single-active simplicity the brand has been moving toward more complex multi-active formulas. This January 2026 launch is among the densest moisturizers it has ever produced, and the value is the kind that makes you double-check the price tag.
Ectoin deserves the marquee position it gets here, because unlike a lot of hyped actives it is genuinely well studied. It is a cyclic amino acid first identified in halophilic bacteria, the extremophile microorganisms that survive in brutally high-salinity environments, where it functions as an osmoprotectant, accumulating inside cells to stabilize proteins against osmotic stress without disrupting normal metabolism. The published literature on topical ectoin documents anti-inflammatory effects through stabilization of membrane proteins, barrier support through organization of the stratum corneum lipid bilayer, and anti-pollution effects through prevention of pollution-driven oxidative damage. The clinically relevant range sits roughly between half a percent and three percent, and most products that include ectoin do so at the lower end as more of a label flourish than a working dose. At two percent, The Ordinary is squarely in the meaningful range, which is exactly the kind of quietly substantive decision that earns the brand its following.
The second pillar is rice lipid chemistry. Oryza sativa lipids sit second in the INCI, the lipid fraction drawn from rice bran that contains phytoceramides, phytosterols, omega fatty acids, and tocotrienols, a composition that mimics the natural lipid matrix of the stratum corneum and provides a botanical route to barrier support alongside the ectoin. Jojoba seed oil rides high in the list as an additional barrier-mimetic emollient, and together these lipids are what let the microemulsion function as a genuine leave-on moisturizer despite its featherlight texture. The third pillar is a comprehensive natural moisturizing factor complex, nine amino acids and PCA stacked together to recreate the small-molecule humectant system the skin makes for itself through filaggrin breakdown. Topical NMF-mimicking formulas are credible humectant strategies, especially for skin with reduced endogenous NMF, and assembling nine amino acids plus PCA is unusually thorough for a moisturizer at this price point.
The supporting cast extends the same rigor. Five sugar and sugar-alcohol humectants, xylitol, fructose, glucose, maltose, and trehalose, stack for diverse water-binding across molecular weights, with trehalose in particular carrying documented anti-inflammatory and barrier-supporting properties beyond simple humectancy. Glycerin, betaine, and pentylene glycol add further humectant chemistry, while allantoin and urea contribute skin conditioning. Hydrogenated lecithin supplies the phospholipid emulsification that creates the microemulsion itself, and the smaller droplet size of a microemulsion is part of why the texture ends up so light and why active penetration improves.
In use, the experience is satisfyingly understated. The milky microemulsion flows easily and absorbs in thirty to sixty seconds with no film and no scent bloom, since it is genuinely fragrance-free. Skin feels calmer and more comfortable almost immediately, with the ectoin's soothing contribution documented at this concentration, and for reactive or rosacea-prone skin the cumulative comfort improvements build over roughly four to six weeks of consistent use. It is the rare moisturizer that does meaningful work while making almost no sensory fuss.
A few caveats are mild and predictable. The jojoba oil means it is not fungal-acne safe, so anyone managing malassezia-driven breakouts should look elsewhere. The lightweight texture is a strength for most skin but may not be enough on its own for very dry skin in harsh winter conditions, where layering an occlusive on top would help. The sixty-milliliter bottle is small for users who apply generously or buy multiples, though a larger 120ml size at $22.50 exists for the budget-minded. And as a January 2026 launch, the cumulative real-world review data is still thin, which is why the data confidence here is medium rather than high; the scoring leans on the strength of the formulation chemistry and the documented evidence behind ectoin rather than years of user feedback. Early distribution was also Sephora-exclusive, which limited availability outside that channel at launch, so depending on where you shop you may find it easier to track down some months on as it rolls out more widely. As with any very new product, the prudent move is to patch test first if your skin is reactive, since the long tail of user experience that surfaces rare sensitivities simply has not accumulated yet.
None of that undercuts what this is. At thirteen dollars for sixty milliliters, with clinical-grade ectoin, rice-derived ceramide chemistry, a nine-amino-acid NMF complex, and a multi-sugar humectant stack, it stands among the strongest sensitive-skin moisturizer values on the global market right now. For sensitive, dry, normal, or combination skin that wants serious barrier-supporting chemistry without paying a prestige premium or wearing a heavy cream, this is an easy, enthusiastic recommendation. Very dry winter skin should treat it as a hydrating layer under something richer, and fungal-acne sufferers should pass, but for nearly everyone else this is The Ordinary doing exactly what it does best, only with more depth than usual.